Economic burden associated with inadequate antidepressant medication management among patients with depression and known cardiovascular diseases: insights from a United States–based retrospective claims database analysis-Reference-Cited by-同舟云学术

Economic burden associated with inadequate antidepressant medication management among patients with depression and known cardiovascular diseases: insights from a United States–based retrospective claims database analysis

Published:2019-11-22 Issue:3 Volume:23 Page:262-270
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

Bangalore Sripal¹,Shah Ruchitbhai²,Gao Xin²,Pappadopulos Elizabeth³,Deshpande Chinmay G.²,Shelbaya Ahmed³⁴,Prieto Rita⁵,Stephens Jennifer²,Chambers Richard⁶,Schepman Patricia³,McIntyre Roger S.⁷⁸

Affiliation:

1. Cardiovascular Outcomes Group, Leon H. Charney Division of Cardiology, New York University School of Medicine, New York, NY, USA;

2. Pharmerit International, LP, Bethesda, MD, USA;

3. Pfizer Inc., New York, NY, USA;

4. Mailman School of Public Health, Columbia University, New York, NY, USA;

5. Pfizer GEP, S.L.U, Alcobendas, Spain;

6. Pfizer Inc., Philadelphia, PA, USA;

7. Mood Disorders PsychoPharmacology Unit University Health Network, University of Toronto, Toronto, Canada;

8. Brain and Cognition Discovery Foundation, Toronto, Canada

Publisher

Informa UK Limited

Subject